PRQR 2.63 (+1.54%)
NL0010872495BiotechnologyBiotechnology

ProQR Therapeutics (PRQR) Financial Metrics

This table shows a selected set of financial data points of ProQR Therapeutics (PRQR). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.35 0 -5.15 144.92M -0.18 6.51M 20.18M -28.73M -28.12M 118.93M
2022 -0.9 0 -3.86 248.65M -0.34 3.59M -69.22M -59.83M -64.42M 94.78M
2021 -0.95 0 -7.47 453.95M -0.39 1.34M -26.5M -56.97M -60.74M 187.52M
2020 -0.93 0 -3.67 170.94M -0.43 1.03M -47.98M -40.11M -46.57M 75.84M
2019 -1.38 0 -6.43 363.03M -0.5 1.93M -44.55M -57.33M -56.48M 111.95M
2018 -1.08 0 -12.73 469.71M -0.45 5.59M -28.81M -35.09M -36.89M 105.58M
2017 -1.72 0 -1.57 68.53M -0.74 0 -35.07M -41.97M -43.64M 48.1M
2016 -1.67 0 -2.77 108.17M -0.47 0 -36.76M -37.32M -39.1M 59.2M
2015 -0.89 0 -8.9 185.31M -0.19 3.24M -25.56M -19.96M -20.83M 94.87M
2014 -1.09 0 -16.28 197.47M -0.2 379K -15.69M -11.74M -12.13M 112.74M
2013 -0.15 0 0 0 -1.34 160K -2.47M -3.19M -3.25M 4.13M
2012 0 0 0 0 0 30K 0 0 0 249K

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.